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Summary
The mammalian DAF-16-like transcription factors, FKHR, FKHRL1, and AFX, function as key regulators of insulin signaling,
cell cycle progression, and apoptosis downstream of phosphoinositide 3-kinase. Gene activation through binding to insulin
response sequences (IRS) has been thought to be essential for mediating these functions. However, using transcriptional
profiling, chromatin immunoprecipitation, and functional experiments, we demonstrate that rather than activation of IRS
regulated genes (Class I transcripts), transcriptional repression of D-type cyclins (in Class III) is required for FKHR mediated
inhibition of cell cycle progression and transformation. These data suggest that a novel mechanism of FKHR-mediated
gene regulation is linked to its activity as a suppressor of tumor growth.
Introduction each substrates for Akt kinase activity (Brunet et al., 1999; del
Peso et al., 1999; Kops et al., 1999; Rena et al., 1999; Takaishi
et al., 1999; Tang et al., 1999). Akt phosphorylation of theseInappropriate activation of phosphoinositide 3-kinase (PI3K)
signaling is intimately connected with the acquisition of a trans- forkhead transcription factors induces binding to 14-3-3 pro-
teins, relocalization to the cytoplasm, and impairment of tran-formed phenotype. Certain retroviruses and DNA tumor viruses
transform rodent and avian cells through activation of this path- scriptional activity (Biggs et al., 1999; Brunet et al., 1999; Ta-
kaishi et al., 1999; Tang et al., 1999; Tomizawa et al., 2000).way. Similarly, in human tumors, genetic alterations of this path-
way, including amplification of PI3KCA, AKT1, and AKT2 genes In PTEN null cells, these factors are constitutively phosphor-
ylated and hence constitutively cytoplasmic. Thus, when exoge-and mutation of the PTEN tumor suppressor, lead to constitutive
activation of Akt family members and constitutive phosphoryla- nously expressed, they are incapable of activating FKHR re-
sponsive promoters (Nakamura et al., 2000). A phosphositetion of Akt substrates (reviewed in Vazquez and Sellers, 2000).
The PTEN tumor suppressor gene encodes a lipid phospha- mutant form of FKHR (FKHR;AAA), in which the three Akt phos-
phorylation sites are altered (S→A), is immune to Akt regulation.tase that specifically dephosphorylates the D3 position of phos-
phatidylinositol 3,4,5-trisphosphophate and phosphatidylinosi- In PTEN null cells, this mutant is constitutively nuclear and
strongly activates FKHR responsive promoters. FKHR;AAA thustol 3,4-bisphosphate (Maehama and Dixon, 1999). In this
capacity, PTEN antagonizes PI3K signaling and regulates the restores FKHR transcriptional activity to PTEN null cells. We
previously found that reconstitution of forkhead activity wassubsequent activation of Akt (reviewed in Vazquez and Sellers,
2000). In cells lacking PTEN, substrates of Akt are aberrantly sufficient to restore the induction of apoptosis in PTEN null
cells that likewise undergo apoptosis upon PTEN reconstitution.phosphorylated.
In C. elegans, the genetic evidence points to a convergence These data are in keeping with other published data demonstra-
ting a role for these forkhead factors in regulating apoptosisof the PI3K/Akt signaling pathway, and in particular of Akt action,
upon the DAF-16 winged-helix transcription factor (Lin et al., (Brunet et al., 1999; Tang et al., 1999). Moreover, reconstitution
of FKHR activity did not induce apoptosis, but rather was suffi-1997; Ogg et al., 1997). The mammalian homologs of DAF-16,
AFX, FKHRL1, and FKHR (hereafter referred to as forkhead) are cient for the induction of a G1 cell cycle arrest in those PTEN
S I G N I F I C A N C E
Emerging data suggest that FKHR, AFX, and FKHRL1, each a substrate for the oncogenic Akt kinases, are critical downstream targets
of the insulin/PI3K signaling pathway. In human tumors, this pathway is frequently deregulated, and these forkhead transcription
factors are inactivated as a result of PTEN gene mutation. Thus, these forkhead factors are likely nonfunctional in a broad spectrum
of human tumors. The data presented here suggest that a novel mechanism of transcriptional regulation, specifically repression of
D-type cyclin transcription, rather than IRS dependent gene activation, accounts for the function of FKHR as a suppressor of tumor
cell growth. These data begin to elucidate how, mechanistically, cell growth regulation differs from the other functional outputs
downstream of FKHR.
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Figure 1. DNA binding and 3xIRS promoter acti-
vation by FKHR proteins
A: (Top panel) Mutation of FKHR residue H215
abolishes binding to an IRS. Extracts from U2-OS
cells transfected with plasmids encoding the in-
dicated FKHR proteins were incubated with a
32P labeled double-stranded IRS oligonucleotide
probe, in either the presence or absence of anti-
Flag antibody. The solid arrow indicates the DNA-
FKHR complex. The open arrow indicates the
DNA-FKHR-antibody complex. (Bottom panel)
Immunoblot detection of the indicated Flag-
FKHR proteins.
B: Mutation of FKHR residue H215 abrogates
transactivation of the 3xIRS promoter. U2-OS cells
were transfected with the 3xIRS reporter plasmid
and pCMV--Gal along with either 0.2 or 0.02 g
of the indicated FKHR expression plasmids. Cell
lysates were prepared, and luciferase activity
was measured and normalized to -galac-
tosidase activity. Results shown are representa-
tive of multiple independent experiments.
null cells that arrest in G1 upon PTEN reconstitution (Nakamura vant FKHR transcriptional targets in PTEN null cells. To do so,
et al., 2000). Medema et al. likewise showed that these forkhead cDNA array-based transcriptional profiling experiments were
transcription factors can act as cell-cycle regulators and do so performed using adenoviral expression of FKHR;AAA to uni-
through transcriptional regulation of p27 (Medema et al., 2000). formly restore FKHR activity to PTEN null 786-O renal carcinoma
Together, these data suggest that forkhead factors are key me- cells.
diators of tumor suppression downstream of PTEN. Forkhead transcription factors, such as HNF3, bind to DNA
In order to understand the mechanisms by which FKHR acts as monomers primarily through helix 3 of the winged-helix do-
as a cell cycle regulator and tumor suppressor, as distinct from main (Clark et al., 1993; Jin et al., 1999). Sequence homology
other functional outputs attributed to forkhead such as meta- and the NMR structure of AFX suggest that FKHR, AFX, and
bolic regulation or apoptosis, expression profiling was per- FKHRL1 likely bind to an IRS element in a similar manner
formed to identify transcriptional targets of FKHR that regulate (Weigelt et al., 2001). Mutation of a conserved histidine to argi-
cell proliferation and cellular transformation. nine in helix 3 abrogates DNA binding in members of this family,
Three classes of FKHR regulated transcripts were identified. and introduction of the H215R mutation in FKHR (FKHR;H215R)
Class I genes were activated by FKHR, required IRS binding or in FKHR;AAA (FKHR;HRAAA) abolished both binding to the
activity, and included the IRS regulated gene IGFBP1. Class IGFBP-1 insulin response element (IRS) in gel shift assays (Fig-
II genes, including Cbl-b, SOD-2, and several DNA-damage ure 1A) and FKHR-mediated activation of a 3xIRS-luciferase
response genes, comprise a major new class of genes (Class reporter (Figure 1B) (Tang et al., 1999). FKHR;HRAAA was hence
IIa) induced by FKHR without a strict requirement for interaction compared to FKHR;AAA in the profiling experiments.
with an IRS element. Cell cycle regulation and suppression of A time course of activation of a 3xIRS promoter-luciferase
transformation did not require direct DNA binding to IRS regu- reporter was used to estimate the likely temporal pattern of
lated promoters, nor the activation of the IGFBP-1 gene cluster. endogenous gene induction following adenoviral mediated ex-
Instead, transcriptional profiling and functional experiments pression of FKHR;AAA. To this end, 786-O cells were trans-
demonstrated that cell cycle inhibition, soft agar growth sup-
fected with the 3xIRS promoter luciferase reporter plasmid and
pression, and tumor suppression correlated with the transcrip-
then infected with either Ad-Vector or Ad-FKHR;AAA. Luciferasetional downregulation of a set of genes (Class III genes) that
activity was assayed from cells harvested at the indicated timeincluded cyclin D1 and D2. Coexpression of cyclin D1 and Cdk4
points (Figure 2A). Ad-FKHR;AAA induced activation of thebypassed the G1 arrest induced by FKHR;AAA, suggesting that
3xIRS promoter at 12 hr, and this activity increased through thesuch downregulation is necessary for the G1 arrest induced by
final time point of 24 hr to a maximum of 6-fold (Figure 2A).FKHR. These data suggest that a novel mechanism of transcrip-
Therefore, a time course of 0 to 28 hr was chosen.tional regulation, specifically transcriptional inhibition or repres-
sion, accounts for FKHR tumor suppressor activity and is sepa-
Expression profilingrable mechanistically from the induction of IRS regulated genes.
Three independent expression profiling experiments were car-
ried out. In experiment 1, 786-O cells infected with Ad-VectorResults
or Ad-FKHR;AAA were collected at 16, 20, 24, and 28 hr after
infection. In experiment 2, 786-O cells infected with Ad-VectorInduction of FKHR activity in PTEN null cells
or Ad-FKHR;AAA were collected at 0, 12, 16, 20, 24, and 28In order to understand how FKHR mediates tumor suppressor
functions downstream of PTEN, we sought to identify the rele- hr. In experiment 3, 786-O cells infected with Ad-Vector, Ad-
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putative unique genes whose expression was altered in
FKHR;AAA expressing cells by at least 2-fold (induced or re-
pressed) at the 24 hr time point in both experiments 1 and 2
were selected. The data from experiments 1, 2, and 3 for this
highly reproducible set were organized by hierarchical clustering
(Eisen et al., 1998) of the log-transformed ratio data (the ratio
of either FKHR;AAA or FKHR;HRAAA to the vector at each time
point) (Figure 3B). Again, 4 major patterns of transcriptional
regulation were seen and were similar to those found by
K-means clustering. A number of genes apparently regulated
in experiments 1 and 2 did not reproduce in experiment 3 (indi-
cated by the brackets in Figure 3B). This may have resulted
from a change in the performance characteristics of the cDNA
probes on the 60K array or possibly from changes in annotation.
Figure 2. Promoter activation and protein production after infection with Not surprisingly, FKHR (black arrow in Figure 3B) itself, presum-
Ad-FKHR;AAA
ably produced from the adenovirus, was the earliest induced gene.
A: Time course of promoter activation following infection with Ad-FKHR;AAA.
Based upon these analyses, 4 classes of genes whose expres-786-O cells were transfected with 3xIRS reporter plasmid and pCMV--gal
sion was altered in these experiments were defined (Figure 3and then infected (MOI of 30) with Ad-Vector (filled circles) or Ad-FKHR;AAA
(open circles). Normalized luciferase activity was determined at the indi- and Supplemental Tables S1–S4 at http://www.cancercell.org/cgi/
cated time points following infection. content/full/2/1/81/DC1). Class I transcripts were those induced
B: Time course of FKHR;AAA or FKHR;HRAAA protein production following
by FKHR;AAA, but not by the vector, nor by the FKHR;adenovirus infection of 786-O cells (from experiment 3 of Figure 3). 786-O
HRAAA mutant. Typified by IGFBP-1, members of this classcells were infected with the indicated adenoviruses. Cell lysates prepared
at 4 hr intervals after infection were immunoblotted with anti-Flag antibody. included DEPP, lumican, decorin, ceruloplasmin, semaphorin
E, and C-type lectin, as well as a number of ESTs. FKHR;AAA-
specific induction was independently confirmed by real-time
quantitative reverse transcriptase-polymerase chain reaction
FKHR;AAA, or FKHR;HRAAA were collected at 0, 8, 12, 16, 20, (Q-PCR) (for DEPP, semaphorin E, and IGFBP-1), by Northern
24, and 28 hr. The production of the FKHR;AAA and analysis (DEPP), and by immunoblot detection (IGFBP-1 and
FKHR;HRAAA proteins from experiment 3 is shown in Figure DEPP) (Figure 4A, Supplemental Figure S1, and data not shown).
2B. 32P-radiolabeled cDNA was generated by oligo-dT primed The promoters of the PEPCK and G6P genes each contain
reverse transcription from total RNA. For each time point, equiv- IRS elements that, in reporter constructs, can be activated by
alent amounts of radiolabeled cDNA were hybridized in replicate forkhead (Ayala et al., 1999; Hall et al., 2000; Schmoll et al., 2000;
to nylon arrays containing either 30,000 cDNAs (30K array) (ex-
Yeagley et al., 2001). Similarly, the FasL and Bim-1 promoters
periments 1 and 2) or 60,000 cDNAs (60K or whole genome
contain FKHR response elements, are activated by FKHRL1,
array) (experiment 3). The normalized expression data files for
and are thought to mediate apoptosis in response to FKHRL1experiments 1, 2, and 3 are available at http://research.dfci.
activation (Brunet et al., 1999; Dijkers et al., 2000). cDNA probesharvard.edu/sellerslab/datasets/index.html.
for these and other genes whose promoters contain insulinAfter application of a minimal intensity (0.8 arbitrary units)
response elements, including tyrosine aminotransferase andand 1.5-fold variation filter, the expression data from experiment
apolipoprotein C III, were present on the arrays, but were not3 was initially organized by K-means clustering into 60 groups
induced by FKHR;AAA expression (Supplemental Figure S2).(Herwig et al., 1999). cDNAs found in clusters in which the
Thus, while adenoviral directed expression of FKHR stronglypattern of expression indicated adenoviral effect were elimi-
activated IGFBP-1 and other Class I targets, such overexpres-nated, as were cDNAs in which gene expression variation over
sion did not result in generalized transcriptional induction oftime was found in only one of the replicates (typically, these
putative IRS-containing promoters.represented a variation in only a single time point in one repli-
Class II was comprised of genes induced by FKHR;AAA,cate). The expression data from the remaining cDNAs were
and to a varying extent or to a greater extent by FKHR;HRAAArefiltered to exclude those not passing a 2-fold variation filter
(Class IIa and Class Iib, respectively). Class IIa genes includedand were reorganized into 8 clusters. One cluster continued to
Cbl-b, Dyrk-2, Superoxide dismutase 2 (SOD2), and Damage-represent expression patterns consistent with poor replicate
specific DNA binding protein 1 (DDB1). The expression patterndata, and the remaining 7 clusters represented 4 dominant pat-
of Cyclin G2 and BTG1, while found in Class I by K-meansterns of expression. Thus, after eliminating cDNAs with poor
clustering, fell into the same tree with Cbl-b when analyzed byreplicate data, the remaining cDNAs (665) were reorganized by
hierarchical clustering. In independent experiments, immu-K-means into 4 clusters (Figure 3A). 487 cDNAs from experiment
noblotting showed that the protein for Cbl-b, a known regulator3 in these 4 clusters were also present on the arrays used in
of PI3K signaling, was induced by both FKHR;AAA andexperiments 1 and 2 and are shown in Figure 3A. These cDNAs
FKHR;HRAAA, while Cyclin G2 expression was confirmed bydo not represent unique genes, but rather a combination of
Q-PCR (Figure 4B).unique genes, ESTs, and, in some cases, more than one cDNA
Class IIb genes were induced by FKHR;HRAAA to a greaterfor the same gene. The temporal pattern of gene expression after
extent than by FKHR;AAA. The most prominent known membersinfection with Ad-Vector, Ad-FKHR;AAA, and Ad-FKHR;HRAAA
of this class were SLC5A3, also known as Na myo-inositolfound in these 4 clusters is shown in Figure 3A.
In parallel, after eliminating duplicate cDNA probes, the 198 cotransporter, and Mxi-I (Figure 4C). Independent Q-PCR and
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Figure 3. Genome-wide patterns of transcriptional regulation by FKHR
Three independent transcriptional profiling experiments were carried out in 786-O renal carcinoma cells as described in the methods.
A: The final 4 clusters as organized by K-means analysis as described in the text.
B: 198 genes that were at least 2-fold induced or repressed in the first two experiments were organized by hierarchical clustering using the data from all
three experiments. The solid arrow indicates FKHR (which is detected on the arrays). Brackets indicate genes whose expression was induced or repressed
in experiments 1 and 2, but not 3.
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Figure 4. Validation of selected transcriptional
targets
A: Class I targets DEPP and IGFBP-1.
B: Class IIa transcripts Cyclin G2 and Cbl-b.
C: Class IIb transcripts SLC5A3 and Mxi1.
D: Class III transcripts IGFBP3 and Cyclin D2. The
indicated members of each class were vali-
dated either by measuring mRNA production at
24 hr after adenoviral infection of either Ad-vec-
tor (white), Ad-FKHR;AAA (red), or FKHR;HRAAA
(blue) by quantitative real-time PCR (second
panel of A, B, C, and D), or by immunoblotting
(fourth panel of A, B, C, and D), and are shown
compared to the temporal pattern of expression
found in experiments 2 and 3 (first and third pan-
els of A, B, C, and D). Red indicates infection
with FKHR;AAA in experiments 2 or 3, and blue
indicates infection with FKHR;HRAAA in experi-
ment 3.
immunoblotting experiments confirmed that in both cases, in- the IGFBP-1 and DEPP promoters (Figure 5). These data sug-
gest that these genes are likely directly activated by FKHRduction was greater with the FKHR;HRAAA mutant (Figure 4C).
Class III genes, including Cyclin D2, Cyclin D1, epiregulin, binding to IRS or IRS-like promoter elements.
On the other hand, class II and III transcripts were regulatedand IGFBP-3 (Figures 3A and 3B), were strongly downregulated
by both FKHR;AAA and FKHR;HRAAA. Q-PCR for IGFBP-3 and both by wild-type FKHR;AAA and, at least in part, by a FKHR
protein (FKHR;HRAAA) that does not interact with IRS elementsimmunoblot detection of Cyclin D2 again confirmed the pattern
of downregulation detected on the arrays (Figure 4D). in vitro (Figure 1) or with Class I promoters in vivo (Figure 5).
Nonetheless, FKHR;HRAAA might retain the ability to interact
with promoter elements either through a second transcriptionFKHR;HRAAA is recruited to Class II and III promoters
factor or through an alternate DNA recognition element. To testClass I transcripts, such as IGFBP-1 and DEPP, were induced
this hypothesis, the DNA extracted from immunoprecipitatedby FKHR;AAA, but not FKHR;HRAAA. If these are direct targets
chromatin was also amplified with primers for the Cyclin G2of FKHR transcription, a prediction is that FKHR;AAA, but not
and Cyclin D1 promoters. Here, the Cyclin G2 (Class II) andFKHR;HRAAA, should be found bound in vivo to the promoters
Cyclin D1 (Class III) promoters were found in association withof these genes. To test this prediction, in vivo crosslinked chro-
matin was prepared from cells expressing Ad-Vector, Ad-FKHR; both FKHR;AAA and FKHR;HRAAA. Thus, FKHR;HRAAA re-
tained the ability to bind these promoters (Figure 5). TheseAAA, or Ad-FKHR;HRAAA and immunoprecipitated with anti-
flag antibody. The bound DNA was extracted and amplified data are consistent with the notion that FKHR can interact with
promoters through direct or indirect binding to an as yet unde-using primers to the IGFBP-1 and DEPP promoters. Indeed,
FKHR;AAA, but not FKHR;HRAAA, was found in complex with fined promoter element(s) (hereafter referred to as IRS-indepen-
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FKHR;AAA and FKHR;HRAAA induce growth arrest
in U87-MG cells
In order to ask whether the results obtained in 786-O cells
could be extended to other PTEN null cells, PTEN null U87-MG
glioblastoma cells were used. These cells undergo a G1 arrest
and growth retardation upon restoration of PTEN or upon resto-
ration of the FKHR-related proteins FKHRL1 and AFX (Cheney
et al., 1998; Furnari et al., 1997, 1998; Medema et al., 2000).
We therefore asked whether FKHR;AAA or the DNA binding
mutant were able to suppress the growth of these cells. To this
end, stable polyclonal pools of U87-MG cells containing the
vector or expressing FKHR;WT, FKHR;AAA, FKHR;H215R, and
FKHR;HRAAA were generated by retroviral transduction fol-
lowed by puromycin selection. The growth rates of such cells
were significantly retarded by both FKHR;AAA and FKHR;
HRAAA (Figure 7A). Interestingly, numerous U87-MG cells in-
fected with FKHR;AAA and FKHR;HRAAA developed a “flat cell”
morphology reminiscent of cells undergoing cellular senes-
cence. These cells were also found to have detectable, senes-
cence-associated -galactosidase (SA--gal) activity. SA--gal
positive “flat” cells were abundantly present in cultures of cells
stably expressing either FKHR;AAA or FKHR;HRAAA, but notFigure 5. Chromatin immunoprecipitation of FKHR-promoter complexes
in cells infected with the backbone retrovirus or with FKHR;In vivo crosslinked chromatin was prepared from 786-O cells infected with
the indicated adenoviruses and immunoprecipitated with anti-Flag anti- H215R or FKHR;WT (Figure 7B and data not shown). Thus, the
body. Bound promoters were detected by PCR amplification using the growth inhibitory properties of FKHR;AAA and FKHR;HRAAA
indicated primer pairs specific for the IGFBP-1, DEPP, Cyclin G2, and Cyclin can be extended to a second PTEN null cell line.
D1 promoters (as indicated). Control lanes represent no DNA, while input
represents DNA extracted from chromatin prior to immunoprecipitation.
FKHR;HRAAA is unable to induce cell death
PTEN null LNCaP prostate adenocarcinoma cells undergo cell
death following reconstitution with either PTEN or FKHR;AAA.
FKHRL1, another member of the Akt-regulated forkhead tran-dent binding). In keeping with these data, transcriptional regula-
scription factor subfamily, induces apoptosis in Rat1 cells andtion by FKHR through binding to nuclear receptors has been
can regulate the promoter of the death effector ligand FasL orobserved by two groups (Schuur et al., 2001; Zhao et al., 2001),
Bim1 (Brunet et al., 1999; Dijkers et al., 2000). In order to askas well as in our lab (I.S. and W.R.S., unpublished data).
whether, in addition to suppressing proliferation, FKHR;HRAAA
also retained apoptotic functions, LNCaP cells were infectedFKHR;HRAAA retains the ability to inhibit cell cycle
with amphotropic backbone retrovirus or retrovirus encodingprogression and suppress tumor formation
FKHR;WT, FKHR;AAA, FKHR;H215R, and FKHR;HRAAA. AfterThe transcriptional profiling data raised the possibility that
puromycin selection, cell viability was determined. While FKHR;FKHR-mediated G1 cell cycle regulation might be separable
AAA completely suppressed cell viability, infection with the ret-from FKHR activation of IRS-dependent genes such as IGFBP-1
rovirus encoding FKHR;HRAAA did not induce cell death, while(and other Class I transcripts). To test this hypothesis, the cell
viable expressing cells comparable in number to the controlcycle distribution of PTEN null 786-O cells infected with either
infections were obtained (Figure 6B).backbone retrovirus or retroviruses directing the expression of
Taken together, these data suggest that the mechanism ofthe indicated FKHR proteins was determined (Figure 6A). In
FKHR-mediated cell cycle regulation and tumor suppression iskeeping with published data, neither FKHR;WT nor FKHR;
completely distinct from both the activation of typical FKHRH215R expression (both cytoplasmic in these cells) led to an
target genes, such as IGFBP-1, and from the mechanisms un-accumulation of cells in G1. However, both FKHR;AAA- and
derlying FKHR mediated apoptosis. The latter functions appearFKHR;HRAAA-expressing cells accumulated in G1. 786-O cells
to require binding to an IRS element and induction of IRS depen-infected with the same retroviruses were also tested for their
dent gene transcription, while the former do not.ability to grow in semisolid media. Here, both FKHR;AAA and
FKHR;HRAAA, but not the vector or FKHR;WT, suppressed the
D-type Cyclin proteins are downregulated in cellsoutgrowth of soft agar colonies (Figure 6C).
expressing FKHR;AAA or FKHR;HRAAAFinally, 1 105 stably transduced 786-O cells were injected
Our data strongly suggest that a novel IRS-independent mecha-into the flanks of nude mice. In each example, the right flank
nism of gene regulation accounts for FKHR growth suppressionwas injected with vector-transduced cells, while the left flank
function. Furthermore, the results of the transcriptional profilingof the same mouse was injected with cells expressing either
experiments suggested that both FKHR;AAA and FKHR;HRAAAFKHR;AAA or FKHR;HRAAA. In this experiment, 6 sites injected
could repress certain transcripts—in particular, D-type cyclins.with vector containing cells formed large, rapidly progressive
To confirm downregulation of cyclin D1 and D2, protein extractstumors. In these same animals, a small tumor formed at 1 of
were prepared from U87-MG cells at 0, 24, 36, and 48 hr afterthe 2 sites injected with FKHR;AAA, while no tumors were seen
at 4 sites injected with FKHR;HRAAA (Figure 6D). infection with Ad-Vector, Ad-FKHR;AAA, or Ad-FKHR;HRAAA.
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Figure 6. FKHR;HRAAA retains FKHR growth and
tumor suppressor activities but fails to induce cell
death
A: FKHR;HRAAA induces a G1 arrest. The cell cy-
cle distribution of 786-O cells infected with back-
bone retrovirus or retroviruses encoding the indi-
cated FKHR proteins was analyzed by FACS
analysis of PI stained cells harvested 48 hr after
infection. The level of expression of the different
FKHR was detected by anti-HA immunoblot, and
the results are shown in the bottom panel.
B: FKHR;HRAAA fails to induce apoptosis in
LNCaP cells. LNCaP cells were infected with the
retrovirus as in A. Cell viability was measured by
MTS assay after selection for 4 days in puromycin.
C: FKHR;HRAAA suppresses colony formation in
soft agar. 786-O cells stably expressing the indi-
cated FKHR protein, generated by retroviral in-
fection, were mixed with DMEM containing 0.3%
agarose and plated onto DMEM containing 0.6%
agarose. Soft agar colonies were photographed
after 4 weeks. The results obtained are represen-
tative of three independent experiments.
D: FKHR;HRAAA inhibits xenograft tumor forma-
tion in nude mice. 1 105 second passage 786-O
cells infected with the indicated retroviruses
were injected into the flanks of nude mice. The
tridimensional tumor measurements were made
weekly and used to calculate tumor volume. In
order to show the growth obtained in one
FKHR;AAA-expressing line, the results are pre-
sented as log-tumor volume. The mean and stan-
dard error of each tumor or injection site is shown.
For the purposes of plotting on a log-scale, injec-
tions sites where no tumor growth was seen were
arbitrarily set to 1 mm3 .
Figure 7. FKHR;AAA and FKHR;HRAAA inhibits cell
growth and induces a senescence phenotype
in U87MG cells
A: U87-MG cells were infected with retroviral su-
pernatant directing the expression of the indi-
cated FKHR proteins. Stable polyclonal cell pop-
ulations were isolated by puromycin selection,
and the number of viable cells at the indicated
days after infection was determined using MTS
assay as described in the Experimental Proce-
dures.
B: U87-MG cells expressing the indicated FKHR
proteins were generated by retroviral infection
as in A. Five days after selection in puromycin,
the cells were stained for SA--gal activity to de-
termine the senescence phenotype as de-
scribed in the Experimental Procedures. These
results were representative of three independent
experiments.
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FKHRL1, and AFX, are central mediators of the transcriptional
response to PI3K signaling. The functional outputs of these
factors, including metabolic responses, apoptosis, cell cycle
regulation, and stress responses, have been thought to depend
primarily upon the interaction of these forkhead factors with an
IRS promoter element and subsequent gene activation.
Here, we find that direct binding to an IRS is not required for
the activation or repression of a number of FKHR transcriptional
targets. Our data also suggest that this binding is not required
for FKHR-dependent tumor suppression. Specifically, a mutant
form of FKHR, which does not interact with an IRS element in
vitro, does not bind to such promoter elements in vivo, and thus
does not activate a class of genes that include prototypic IRS
regulated genes such as IGFBP-1, nonetheless repressed tran-
scription of a class of genes that includes D-type cyclins, bound
Figure 8. Downregulation of D-type cyclins by FKHR;AAA and FKHR;HRAAA
to such promoters in vivo, and retained the cell cycle regulatoryis required for induction of a cell cycle arrest
and tumor suppressor properties of FKHR.A: U87-MG cells were infected with Ad-Vector, Ad-FKHR;AAA, and Ad-
Two possible mechanisms could account for IRS-indepen-FKHR;HRAAA. Protein lysates were prepared at the indicated time points
dent gene regulation through FKHR and the presence of theafter infection and immunoblotted with anti-Rb, anti-cyclin D1, anti-cyclin
D2, anti-p27, and anti-FLAG antibodies. FKHR;HRAAA mutant bound to Class II and III promoters. First,
B: Coexpression of Cyclin D1 overrides a FKHR;AAA mediated G1 arrest. FKHR might interact with other transcription factors and modu-
786-O cells were transfected with a plasmid encoding for CD19 and either
late their activities. The Estrogen receptor (ER), as an example,vector or a plasmid encoding FKHR;AAA ,either alone or together with
induces gene activation through both a classical estrogen re-plasmids directing the expression of Cyclin D1;WT, Cyclin D1;WT, and Cdk4,
and Cyclin D1;KE. The transfected cells were fixed, and stained with FITC- ceptor response (ERE) element and a nonclassical response
conjugated anti-CD19 antibodies and propidium iodide. The cell cycle element (AP-1) (Jakacka et al., 2001; Webb et al., 1999). In this
distribution of the CD19() and hence successfully transfected cells was model, it is also possible that at certain promoters, FKHR might
determined by FACS analysis. The results shown here are the average of
bind simultaneously to an IRS element and to a second promoterreplicates and are representative of two independent experiments.
site through an interaction with another transcription factor.
Such a model might account for the retention of partial but not
full activity of FKHR;HRAAA toward a number of the Class IIa
transcripts. Whether such promoter and transcription factor in-Immunoblots prepared from these extracts showed marked
teractions account, at least in part, for the regulation of Classdownregulation of the Cyclin D1 and D2 protein after adenoviral
II and III genes is under investigation.infection with either Ad-FKHR;AAA or Ad-FKHR;HRAAA. Loss
Alternatively, the HR mutant of FKHR might retain directof Cyclin D protein was accompanied by a loss of the phosphor-
DNA binding to a promoter element other than the classic IRS.ylated forms of the protein product of the RB-1 gene (pRB), the
The majority of the DNA contacts made by winged helix tran-primary substrate of D-type cyclins (Figure 8A). Similar results
scription factors such as HNF-3 and genesis are made throughwere obtained in 786-O cells (Figure 4D and data not shown).
helix 3 lying in the DNA major groove. However, domains flank-In U87-MG cells, introduction of FKHR;AAA also induced an
ing helix 3 also make additional DNA contacts both with theincrease in p27, consistent with previously published data (Me-
phosphate backbone and with base atoms (Clark et al., 1993;dema et al., 2000). FKHR;HRAAA, however, did not lead to a
Jin et al., 1999). Thus, it is possible that FKHR could interactchange in the levels of p27, yet retained the ability to downregu-
with a new DNA response element present in Class IIa, IIb, andlate D-type cyclins and to inhibit cell proliferation (Figure 8A).
III without the requirement for the helix 3 Histidine residue.These data indicate that the induction of p27 is not necessary
Our data also suggest that transcriptional inhibition offor the regulation of proliferation by FKHR.
D-type cyclins, rather than gene activation (of Class I genes forIn order to ask whether downregulation of D-type cyclins
example), accounts for tumor suppression linked to FKHR. Awas required for the induction of a G1 arrest by FKHR, we next
concern here is that expression of FKHR proteins might nonspe-asked whether restoration of Cyclin D1 was sufficient to bypass
cifically squelch transcription by competing away coactivators.a FKHR;AAA-induced cell cycle arrest. 786-O cells were tran-
Class III genes, however, comprised a small minority of thesiently transfected with FKHR;AAA, along with plasmids encod-
54,684 cDNAs spotted on the complete genome array, the vasting CD19 and either vector or Cyclin D1 and Cdk4. Expression
majority of which did not change in response to FKHR;HRAAA.of cyclin D1/cdk4 completely reversed the cell cycle arrest in-
Moreover, treatment of Ad-FKHR;AAA-infected cells with theduced by FKHR;AAA (Figure 8B), while coexpression of a form
histone deacetylase inhibitor trichostatin A reversed FKHR-of Cyclin D1 (Cyclin D1;KE) that fails to activate cdk4 was defec-
mediated inhibition of Cyclin D1 and D2 (I.S. and W.R.S., unpub-tive, making it unlikely that sequestration of p27 accounts for
lished data), strongly suggesting that FKHR can act as a specificthe override activity of Cyclin D1. Thus, FKHR can regulate cell
transcriptional repressor for Class III genes. In functional experi-cycle progression through the regulation of D-type cyclins.
ments, FKHR;HRAAA retained the ability to suppress Cyclin D1
and D2 protein levels, induce a G1 arrest in 786-O cells, andDiscussion
suppress soft agar and xenograft growth. We have also tested
FKHR mutants lacking the C-terminal transactivation domainData from studies in C. elegans and in mammalian cells suggest
that daf-16 and the daf-16-like transcription factors, FKHR, and find that they likewise retain the ability to arrest cells in G1
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and to suppress soft agar growth (I. S. and W.R.S., unpublished emerging data in C. elegans, suggest that in mammalian cells,
the daf-like FKHR family members play an important role in thedata). Thus, transactivation is not required. Taken together,
these data suggest that tumor suppression by FKHR is linked cellular response to oxidative stress and a novel role in mediat-
to transcriptional repression rather than to gene activation. Our ing the cellular response to DNA damage through the activation
data also support the idea, put forth by a number of groups of class IIa and IIb genes.
(Brunet et al., 1999; Dijkers et al., 2000; Tang et al., 1999), that Taken together, the data presented here support a novel
forkhead factors require IRS binding activity in order to induce mechanism underlying the activity of FKHR as a cell cycle regu-
apoptosis. FKHR;HRAAA suppressed tumor xenograft forma- lator and tumor suppressor. Specifically, these activities are
tion in 786-O cells, but failed to induce apoptosis in LNCaP linked to FKHR recruitment to promoters through an IRS-inde-
cells, raising the possibility that in such “apoptosis sensitive” pendent mechanism and to downregulation of Class III targets,
cells, one might be able to test whether tumor suppression is and are separable from IRS-dependent activation of classical
or is not separable from IRS-dependent induction of apoptosis. IRS dependent promoters.
Medema et al. found that FKRHL1 and AFX could induce
Experimental proceduresp27 protein and mRNA, and moreover that p27 null cells were
partially resistant to an AFX-induced G1 arrest (Medema et al.,
Cell lines, cell culture, retroviral infection, plasmid transfection,2000). In keeping with these data, we previously found that
and MTS assay
FKHR;AAA reintroduction results in a change in the protein half- LNCaP, 786-O, and U2-OS cells were maintained as previously described.
life of p27 (Nakamura et al., 2000). These results suggested that U2-OS,φX-A cells were transfected by the BBS-CaCl2 method, and retroviral
forkhead growth suppression is due, at least in part, to the supernatants produced as previously described (Pear et al., 1993; Sellers
et al., 1998). 786-O cells were transfected using Fugene reagent (Rocheregulation of p27. Data presented here suggest that while p27
Applied Science). LNCaP cell viability and U87-MG cell growth were assayedinduction may yet be sufficient, it is not necessary for FKHR-
using the AQueous non-Radioactive Cell Proliferation Assay (Promega) asmediated growth and tumor suppression. Similarly, this group
previously described (Nakamura et al., 2000). Cell cycle analysis and senes-has independently found that forkhead factors can transcrip-
cence-associated -galactosidase staining were performed as previously
tionally downregulate D-type cyclins and this, at least in part, described (Dimri et al., 1995; Sellers et al., 1998). Colony formation was
accounts for forkhead-mediated regulation of G1 progression determined by suspending 786-O cells in 2 DMEM with 0.3% agarose and
(R. Medema, personal communication). In a genetic test of the plating on a layer of 0.6% agarose in DMEM. Cells were fed every 3 days
with 2 DMEM containing 0.3% agarose. Xenograft growth was determinedrelationship between PI3K-mediated proliferative signaling and
by injecting 1 105 cells from the second passage of retrovirally transducedp27 function, when PTEN heterozygous mice were mated with
786-O cells into the flanks of nu/ female mice (Taconic) in 100 l PBS.p27 heterozygous mice, a cooperative increase in the develop-
Detectable tumors were measured weekly and mice were sacrificed whenment of prostate cancers was noted (Di Cristofano et al., 2001).
any tumor measurement exceeded 1.5 cm.
These in vivo data raised the possibility that PI3K-dependent
proliferative signals are not simply redundant with p27 loss. Plasmids
Taken together, these data suggest that FKHR can regulate cell The plasmids pCDNA3-Flag-FKHR, pCDNA3-Flag-FKHR;H215R, pCDNA3-
Flag-FKHR;AAA, pBABE-puroL, pBABE-puroL-HA-FKHR, pBABE-puroL-cycle progression through at least two mechanisms, induction
HA-FKHR;AAA, pBABE-puroL-HA-FKHR;H215R, pCMV-Gal, pCD19, andof p27 and downregulation of D-type cyclins. This latter mecha-
pGL2promoter-3xIRS were described previously (Nakamura et al., 2000).nism may begin to explain the in vivo synergy between p27 loss
pRcCMV-Cyclin D1;WT, pRcCMV-Cyclin D1;KE, and pRcCMV-CDK4 wereand deregulated PI3K signaling.
the gift of J. Lamb and M. Ewen and were described previously (Neuman
While the primary goal of these experiments was to under- et al., 1997); pCDNA3-Flag-FKHR;HRAAA was the gift of E. Tang, F. Barr,
stand the nature of FKHR’s role as a cell cycle regulator and and K. Guan (Tang et al., 1999). pAD-Track-CMV was the gift of K. Polyak
as a growth/tumor suppressor, it is of interest to note that several and B. Vogelstein. Inserts liberated by partial HindIII and complete XbaI
digestion of pCDNA3-Flag-FKHR;AAA and pCDNA3-Flag-FKHR;HRAAAof the Class II genes appear to be involved in cellular responses
were ligated to HindIII/XbaI-restricted pAD-TrackCMV to give pAD-Track-to oxidative stress (SOD2, GCLC), osmotic stress (SLC5A3),
Flag-FKHR;AAA and pAD-Track- Flag-FKHR;HRAAA. A PCR amplified insertand DNA damage (DDB1 and Cyclin G2). In particular, SOD2
of pCDNA3-Flag-FKHR;HRAAA was digested with BamH1/XhoI and ligatedplays key roles in responding to oxidative stresses. The mamma-
to similarly restricted pBABE-puroL-HA to give pBABE-puroL-HA-
lian SOD2 protein is a mitochondrial Mn-dependent superoxide FKHR;HRAAA.
dismutase encoded by the SOD-2 gene located on chromosome
6. In C. elegans, there are 4 SOD genes. SOD2 and 3 are both Generation of adenoviruses
Ad.FKHR;AAA and Ad.FKHR;HRAAA were generated with the pAD-EasyMn-dependent and SOD-3 is mitochondrial in localization. In
system (He et al., 1998). Briefly, linearized shuttle plasmids were cotrans-C. elegans, mutations in daf-2 or age-1 that confer oxidative
fected with pAdEasy-1 into BJ5183 cells. After isolation, recombinant adeno-stress resistance (oxr) result in the induction of sod-3 (Honda
viral DNA was restricted with PacI and transfected into 293 cells. Infectiousand Honda, 1999). A number of genes that are known to “re-
adenovirus was amplified in 293 cells. Purified virus was isolated by freeze-
spond” to DNA damage were also found in class II, including thaw extraction followed by CsCl gradient purification and titered by plaque
DDB1 (Dualan et al., 1995), BTG1 (Cortes et al., 2000), and lysis.
Cyclin G2 (Bates et al., 1996). While this work was under review,
Antibodies, immunoblotting, protein extraction,a direct role for FKHRL1 induction of the GADD45 gene in
and luciferase assaysrepairing DNA damage was demonstrated (Tran et al., 2002).
M5 anti-Flag antibody (Sigma) was used at 10 g/ml. HA.11 (Covance),In these same experiments, Cyclin G2 was also identified as a
anti-GSK3, anti-phospho-GSK3, anti-phospho-Akt, anti-Akt (all from Cellpotential FKHRL1 transcriptional target.
Signaling Technology), anti-p27 antibody (Transduction laboratories), G3-
As mentioned above, in C. elegans, mutations in daf-2 and 245 anti-RB antibody (Pharmingen), anti-Cyclin D1 antibody (NeoMaker),
age-1 lead to increased resistance to oxidative stress, UV, and anti-Cdk4 antibody (C-22, Santa Cruz), and Cyclin D2 antibody (M-20 Santa
Cruz) were used at a dilution of 1:1000. Anti-GAPDH (Biodesign International)heat (Honda and Honda, 1999). Our data, together with the
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was used at 1:5000. Anti IGFBP1 (Biogenesis) and anti-Cbl-B antibody TSEI (0.1%SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1),
(H121, Santa Cruz) were used at a dilution of 1:500. Anti MxiI antibody (BD and 150 mM NaCl), TSEII (0.1%SDS, Triton X-100, 2 mM EDTA, 20 mM
BioScience) was used at a dilution of 1:250. Luciferase and -galactosidase Tris-HCl [pH 8.1], and 500 mM NaCl), buffer III (0.25 M LiCl, 1% NP-40, 1%
activity assays were performed as previously described (Sellers et al., 1998). deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl [pH 8.1]), and finally with
TE. Bound DNA was eluted by incubating the beads in 100 l of 1% SDS
Electrophoretic mobility shift assay and 0.1 M NaHCO3) for 8 hr at 65C. The input DNA was diluted with 80 l
Cells were lysed in 50 mM Tris (pH 8.0), 100 mM NaCl, 2 mM EGTA, 10 of PBS and incubated at 65C for 8 hr. DNA was purified using the PCR
mM NaF, 40 mM -gycerolphosphate, 0.5% Triton-X100, 2 mM DTT, 1 mM purification kit (Qiagen). The indicated promoter fragments were detected
aprotinin, and 1 mM PMSF. 32P labeled annealed double-stranded oligonu- with the primers as indicated in Figure 5.
cleotides containing the IGFBP-1 IRS site (5-CACTAGCAAAACAAACTTAT
TTTGAACAC-3) were prepared as previously described (Tang et al., 1999). Acknowledgments
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